Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Hepatitis virus c" patented technology

Hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans.

Recombinant Hepatitis C Virus Glycoprotein, Composition and Its Application

This disclosure provides a recombinant hepatitis C virus glycoprotein comprising heterodimers of E1 and E2 glycoproteins having at least 60% homology with SEQ ID No. 1, engineered furin protease cleavage sites, and hydrophilic amino acid linkers, wherein the E1 and E2 glycoproteins partially or completely lack their respective transmembrane domains. This document further provides nucleic acids encoding the recombinant hepatitis C virus glycoprotein, nanoparticle conjugates comprising the recombinant hepatitis C virus glycoprotein, and compositions comprising the recombinant hepatitis C virus glycoprotein, the nucleic acid, or the nanoparticle conjugate. Applications of the recombinant hepatitis C virus glycoprotein or compositions comprising the glycoprotein are also envisioned.
Owner:AMSTERDAM UMC

CircRNA vaccine for anti-infectious hematopoietic organ necrosis virus and construction method and application thereof

PendingCN122440804ANecrovirusTGE VACCINE
The present application relates to a circRNA vaccine for anti-infectious hematopoietic necrosis virus, the circRNA vaccine is a covalently closed circular structure, comprising an internal ribosome entry site, a G protein sequence of the infectious hematopoietic necrosis virus, and a Kozak sequence located between the internal ribosome entry site and the G protein sequence of the infectious hematopoietic necrosis virus;The circRNA vaccine comprises a cyclization connection sequence formed by a fish tRNA Leu I type intron self-splicing;The internal ribosome entry site is one or more of the following: coxsackievirus 3 IRES, infectious pancreatic necrosis virus IRES, encephalomyocarditis virus IRES, Ythdc2 IRES, and hepatitis C virus IRES;The amino acid sequence of the G protein of the infectious hematopoietic necrosis virus has at least 90% sequence identity with the amino acid sequence encoded by SEQ ID NO. 1.
Owner:EAST CHINA UNIV OF SCI & TECH

Mobile terminal-based postpartum hepatitis c referral management system

The application discloses a postpartum hepatitis C referral management system based on a mobile terminal and relates to the medical management field.The system comprises a medical communication module, a data entry module and an index preset module.The medical communication module is used for integrating the communication permission of the mobile terminal and providing a plurality of communication channels.The data entry module is used for periodically collecting and entering the liver function indexes, the hepatitis C virus load data and the emotional evaluation scores of puerpera through the medical communication module.The index preset module is used for presetting the benchmark feeding indexes of future periods according to a newborn growth model.The risk prediction module is used for collecting the data of the current period data entry module and the preset feeding indexes of the next period based on the risk prediction model.The risk coefficient of breastfeeding behavior is dynamically predicted by using the risk prediction model, the potential risks under different feeding schemes are quantitatively evaluated, the high-risk puerpera are early identified, the disease deterioration or the risk of mother-to-child transmission caused by delayed intervention is reduced, the human error is reduced, and the accuracy and response speed of postpartum hepatitis C management are improved.
Owner:CHANGSHA SECOND HOSPITAL (CHANGSHA MATERNAL & CHILD HEALTH HOSPITAL HEXI BRANCH)

A process for purifying a recombinant antigen of hepatitis c virus

ActiveCN224485033UAntigenMedicine
The utility model provides a kind of HCV recombination antigen purification process device, specifically relates to antigen purification field, filler in chromatography column is nickel column filler;The upper and lower sides of interlayer are respectively equipped with water inlet and water outlet;Water inlet is sequentially connected constant-current pump, pre-cooling water bucket by water inlet rubber tube;Water outlet is connected with pre-cooling water bucket by water outlet rubber tube;Protein purification complete system includes conductivity meter, electric ultraviolet light detector, PH detector;Constant-current A pump and constant-current B pump one end are connected with sample A barrel, sample B barrel respectively by import connection pipe, and constant-current A pump and constant-current B pump other end are connected with the liquid inlet of chromatography column by import connection pipe through mixer;The liquid outlet of chromatography column is connected with sample barrel by outlet connection pipe sequentially through conductivity meter, electric ultraviolet light detector, pH detector.The utility model can reduce the tedious operation in experimental process to make test process more succinct, while guaranteeing the production activity and purity of recombination antigen.
Owner:NANJING JINGDA BIOTECHNOLOGY CO LTD